In order to make the prediction model more accurate, AFP, Barcelona staging and target therapy were added, and the nomogram involving these indicators presented satisfactory prediction ability compared with other models without GD, further indicating its potential as a clinical tool to predict the PFS and OS in patients with HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.